{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Dolby Laboratories, Inc.
Dolby Laboratories Stock Plummets to New 52-Week Low at $64.38
Dolby Laboratories, Inc. has reached a 52-week low, trading at USD 64.38 as of November 7, 2025, following a 17.7% decline in stock price over the past year. The company faces challenges with declining profits and flat sales growth, despite strong institutional interest and a notable market capitalization.
Dolby Laboratories Stock Hits 52-Week Low at $64.50
Dolby Laboratories, Inc. has hit a new 52-week low, trading at USD 64.50 as of October 30, 2025. The company has experienced a 17% decline in stock price over the past year, with recent financial results showing significant decreases in pre-tax and net profits, alongside flat sales growth.
Dolby Laboratories Hits New 52-Week Low at $64.56 Amid Declining Sales
Dolby Laboratories, Inc. has hit a new 52-week low, trading at USD 64.56. The company, with a market capitalization of USD 7,024 million, faces challenges including declining profits and modest sales growth. Its financial metrics reveal a P/E ratio of 27.00 and a low cash position of USD 1,507.67 million.
Dolby Laboratories Stock Hits 52-Week Low at $67.10
Dolby Laboratories, Inc. has hit a new 52-week low, with its stock price declining significantly over the past year. The company reported decreases in pre-tax and net profits, while cash reserves have also diminished. Despite flat growth in sales and operating profit, institutional investors have shown increased interest.
Is Dolby Laboratories, Inc. overvalued or undervalued?
As of October 17, 2025, Dolby Laboratories, Inc. is considered attractive but overvalued, with a P/E ratio of 27 compared to the peer average of 25.89, and a year-to-date return of -11.97%, underperforming the S&P 500's 13.30%.
Dolby Laboratories, Inc. Experiences Revision in Stock Evaluation Amid Competitive Software Landscape
Dolby Laboratories, Inc. has recently adjusted its valuation, with a P/E ratio of 27 and a price-to-book value of 2.80. Key financial metrics include an EV to EBIT of 22.83 and a PEG ratio of 2.73, showcasing its operational efficiency and competitive position within the software industry.
Is Dolby Laboratories, Inc. overvalued or undervalued?
As of October 17, 2025, Dolby Laboratories, Inc. is considered fairly valued with a P/E ratio of 27, an EV to EBITDA of 17.08, and a Price to Book Value of 2.80, indicating it is attractively priced compared to peers like Duolingo and Qualys, despite underperforming the S&P 500 over the past year.
Is Dolby Laboratories, Inc. overvalued or undervalued?
As of October 17, 2025, Dolby Laboratories, Inc. is considered attractive but overvalued, with a P/E ratio of 27 exceeding its peers' averages, and a year-to-date return of -11.97%, suggesting it may not be a compelling investment at its current valuation.
Dolby Laboratories Stock Hits 52-Week Low at $67.54
Dolby Laboratories, Inc. has reached a 52-week low of USD 67.54, reflecting a notable decline in its stock price over the past year. The company faces challenges in growth, with modest increases in net sales and operating profit, alongside significant drops in quarterly profits.
Dolby Laboratories Hits 52-Week Low as Stock Drops to USD 67.83
Dolby Laboratories, Inc. has hit a new 52-week low, reflecting a notable decline in its stock price over the past year. The company reported significant drops in pre-tax and net profits, alongside a modest annual sales growth rate. Its financial metrics suggest a challenging environment for the small-cap software firm.
Dolby Laboratories Experiences Revision in Stock Evaluation Amid Market Dynamics
Dolby Laboratories, Inc. has recently revised its evaluation amid fluctuating market conditions. The company's stock is currently priced at $72.38, reflecting volatility over the past year. Performance metrics indicate challenges, with returns lagging behind the S&P 500 across multiple time frames, underscoring competitive pressures in the industry.
Is Dolby Laboratories, Inc. technically bullish or bearish?
As of September 19, 2025, Dolby Laboratories, Inc. is in a bearish trend with moderate strength, indicated by bearish MACD and moving averages, while underperforming the S&P 500 with year-to-date and one-year returns of -7.32% and -1.20%, respectively.
Is Dolby Laboratories, Inc. technically bullish or bearish?
As of September 19, 2025, Dolby Laboratories, Inc. is in a bearish trend with weak momentum indicators, underperforming the S&P 500 year-to-date by -8.35% compared to its 13.31% gain.
Is Dolby Laboratories, Inc. technically bullish or bearish?
As of September 9, 2025, Dolby Laboratories, Inc. shows a bearish technical trend with weak momentum, underperforming the S&P 500 year-to-date and over the past year.
Is Dolby Laboratories, Inc. overvalued or undervalued?
As of July 7, 2025, Dolby Laboratories, Inc. is considered an attractive investment due to its undervalued stock, with a P/E ratio of 27 compared to peers and competitive EV to EBITDA, despite underperforming the S&P 500 in recent years.
Is Dolby Laboratories, Inc. overvalued or undervalued?
As of May 1, 2025, Dolby Laboratories, Inc. is considered fairly valued with an attractive rating, showing a P/E ratio of 27, an EV to EBITDA of 17.08, and a PEG ratio of 2.73, despite underperforming the S&P 500 year-to-date.
Is Dolby Laboratories, Inc. technically bullish or bearish?
As of June 13, 2025, Dolby Laboratories, Inc. is in a bearish trend with moderate strength, indicated by bearish MACD and moving averages, mixed signals from KST and Dow Theory, and underperformance relative to the S&P 500.
Who are in the management team of Dolby Laboratories, Inc.?
As of March 2022, the management team of Dolby Laboratories, Inc. includes CEO Kevin Yeaman and several independent directors, including Peter Gotcher (Chairman), Micheline Chau, David Dolby, N. William Jasper, Simon Segars, and Roger Siboni.
What does Dolby Laboratories, Inc. do?
Dolby Laboratories, Inc. designs and manufactures audio and imaging products for the entertainment industry, with recent net sales of $370 million and a market cap of approximately $7.11 billion. Key financial metrics include a P/E ratio of 27.00 and a dividend yield of 1.73%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
